Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / CLDX - Why Is Inflammation Disease-Focused Celldex Therapeutics Stock Trading Higher Today? | Benzinga

CLDX - Why Is Inflammation Disease-Focused Celldex Therapeutics Stock Trading Higher Today? | Benzinga

Celldex Therapeutics Inc.

Celldex Therapeutics Inc (NASDAQ: CLDX) released topline results from its Phase 2 trial of barzolvolimab in patients with moderate to severe chronic spontaneous urticaria (CSU) refractory to antihistamines, including patients who received prior biologics. 

CSU is characterized by the occurrence of hives or wheals for six weeks or longer ...

Full story available on Benzinga.com
Stock Information
Company Name: Celldex Therapeutics Inc.
Stock Symbol: CLDX
Market: NASDAQ
Website: celldex.com
Menu
CLDX CLDX Quote CLDX Short CLDX News CLDX Articles CLDX Message Board
Get CLDX Alerts

News, Short Squeeze, Breakout and More Instantly...